This slide deck walks through the initial results of the Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study, conducted in Benin, Nigeria, and Uganda. The study aims to assess patients’/caregivers’ preference for a pediatric DTG regimen over their previous regimen, when transitioned from another regimen.
